Photo by museumsvictoria from unsplash
No drug has ever delayed islet cell destruction. Now that teplizumab has, the challenge turns to identifying eligible recipients for the treatment. No drug has ever delayed islet cell destruction.… Click to show full abstract
No drug has ever delayed islet cell destruction. Now that teplizumab has, the challenge turns to identifying eligible recipients for the treatment. No drug has ever delayed islet cell destruction. Now that teplizumab has, the challenge turns to identifying eligible recipients for the treatment.
Keywords:
keeps diabetes;
anti cd3;
diabetes bay;
drug;
drug keeps;
cd3 drug
Journal Title: Nature Biotechnology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Biotechnology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!